Other Filers
Exhibits
S-4
from S-4 355 pages S-4
08/14/13
EX-3.1.1
from S-4 8 pages Certificate of Merger of Sky Growth Acquisition Corporation With and Into Par Pharmaceutical Companies, Inc. Under Section 251 of the General Corporation Law of the State of Delaware
08/14/13
EX-3.1.2
from S-4 3 pages Certificate of Merger of Admiral Acquisition Corp. and Anchenincorporated
08/14/13
EX-3.1.3
from S-4 2 pages Amended and Restated Articles of Incorporation of Anchen Pharmaceuticals, Inc. a California Corporation
08/14/13
EX-3.1.4
from S-4 5 pages Certificate of Incorporation of Kali Laboratories, Inc
08/14/13
EX-3.1.5
from S-4 5 pages Certificate of Incorporation of Par, Inc
08/14/13
EX-3.1.6
from S-4 8 pages Certificate of Incorporation of Par Pharmaceutical, Inc
08/14/13
EX-3.2.1
from S-4 11 pages Amended and Restated By-Laws of Par Pharmaceutical Companies, Inc. Section 1. Law, Certificate of Incorporation and By-Laws
08/14/13
EX-3.2.2
from S-4 7 pages Bylaws of Anchen Incorporated
08/14/13
EX-3.2.3
from S-4 19 pages Bylaws of Anchen Pharmaceuticals, Inc
08/14/13
EX-3.2.4
from S-4 8 pages By-Laws of Kali Laboratories, Inc. ***********************
08/14/13
EX-3.2.5
from S-4 13 pages By-Laws of Par, Inc
08/14/13
EX-3.2.6
from S-4 13 pages By-Laws of Par Pharmaceutical, Inc
08/14/13
EX-4.1
from S-4 141 pages Indenture Dated as of September 28, 2012 Between Sky Growth Acquisition Corporation, to Be Merged With and Into Par Pharmaceutical Companies, Inc., and Wells Fargo Bank, National Association, as Trustee 7 3/8% Senior Notes Due 2020
08/14/13
EX-4.2
from S-4 4 pages Supplemental Indenture (This “Supplemental Indenture”), Dated as of September 28, 2012 Among Par Pharmaceutical Companies, Inc., a Delaware Corporation (The “Issuer”), the Guarantors and Wells Fargo Bank, National Association, a National Banking Association, as Trustee (The “Trustee”)
08/14/13
EX-4.4
from S-4 44 pages Registration Rights Agreement by and Between Sky Growth Acquisition Corporation and Goldman, Sachs & Co. Dated as of September 28, 2012 Registration Rights Agreement
08/14/13
EX-4.5
from S-4 5 pages Registration Rights Agreement Joinder With Respect to the Registration Rights Agreement for Sky Growth Acquisition Corporation $490,000,000 7 3/8% Senior Notes Due 2020
08/14/13
EX-5.1
from S-4 6 pages Legal opinion
08/14/13
EX-5.2
from S-4 3 pages Legal opinion
08/14/13
EX-10.11
from S-4 536 pages $1,205,000,000 Credit Agreement Dated as of September 28, 2012 Among Sky Growth Acquisition Corporation, Which on the Closing Date Shall Be Merged With and Into Par Pharmaceutical Companies, Inc., With Par Pharmaceutical Companies, Inc. Surviving Such Merger as the Parent Borrower, Par Pharmaceutical, Inc., as Co-Borrower, Sky Growth Intermediate Holdings II Corporation, as Holdings, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, and the Other Lenders Party Hereto
08/14/13
EX-10.12
from S-4 62 pages Security Agreement Dated as of September 28, 2012 Among Sky Growth Acquisition Corporation, Which on the Closing Date Shall Be Merged With and Into Par Pharmaceutical Companies, Inc., With Par Pharmaceutical Companies, Inc. Surviving Such Merger as a Borrower, Sky Growth Intermediate Holdings II Corporation, as Holdings, Par Pharmaceutical, Inc., as Co-Borrower, the Subsidiary Guarantors Party Hereto From Time to Time, and Bank of America, N.A., as Administrative Agent
08/14/13
EX-10.13
from S-4 22 pages Guaranty Dated as of September 28, 2012 Among Sky Growth Intermediate Holdings II Corporation, as Holdings, the Other Guarantors Party Hereto From Time to Time, and Bank of America, N.A., as Administrative Agent
08/14/13
EX-10.14
from S-4 394 pages Amendment No. 1
08/14/13
EX-10.15
from S-4 13 pages Amendment No. 2
08/14/13
EX-10.16
from S-4 289 pages Amendment No. 3
08/14/13
EX-10.17
from S-4 23 pages Amended and Restated Employment Agreement
08/14/13
EX-10.18
from S-4 23 pages Amended and Restated Employment Agreement
08/14/13
EX-10.19
from S-4 24 pages Amended and Restated Employment Agreement
08/14/13
EX-10.20
from S-4 12 pages Management Services Agreement
08/14/13
EX-10.21
from S-4 14 pages Sky Growth Holdings Corporation 2012 Equity Incentive Plan
08/14/13
EX-10.22
from S-4 6 pages Sky Growth Holdings Corporation 2012 Equity Incentive Plan Long-Term Cash Incentive Award Agreement
08/14/13
EX-10.23
from S-4 15 pages Sky Growth Holdings Corporation 2012 Equity Incentive Plan This Award and Any Securities Issued Upon Exercise of This Stock Option Are Subject to Restrictions on Voting and Transfer and Requirements of Sale and Other Provisions as Set Forth in the Management Stockholders’ Agreement. Sky Growth Holdings Corporation Strongly Encourages You to Seek the Advice of Your Own Legal and Financial Advisors With Respect to Your Award and Its Tax Consequences. Non-Statutory Stock Option Agreement
08/14/13
EX-10.24
from S-4 10 pages Sky Growth Holdings Corporation 2012 Equity Incentive Plan
08/14/13
EX-10.25
from S-4 6 pages Sky Growth Holdings Corporation 2012 Equity Incentive Plan Restricted Stock Unit Agreement This Award and Any Securities Delivered Hereunder Are Subject to Restrictions on Voting and Transfer and Requirements of Sale and Other Provisions as Set Forth in the Management Stockholders’ Agreement. Sky Growth Holdings Corporation Strongly Encourages You to Seek the Advice of Your Own Legal and Financial Advisors With Respect to Your Award and Its Tax Consequences
08/14/13
EX-10.26
from S-4 24 pages Amended and Restated Employment Agreement
08/14/13
EX-10.27
from S-4 10 pages Separation Agreement and Release
08/14/13
EX-12
from S-4 ~5 pages Computation of ratios
08/14/13
EX-16
from S-4 1 page Change in certifying accountant
08/14/13
EX-21
from S-4 1 page Subsidiaries of the registrant
08/14/13
EX-23.1
from S-4 1 page Consent of expert or counsel
08/14/13
EX-25.1
from S-4 7 pages Statement of eligibility of trustee
08/14/13
EX-99.1
from S-4 17 pages Letter of Transmittal
08/14/13
EX-99.2
from S-4 6 pages Offer to Exchange 7.375% Senior Notes Due 2020 for All Outstanding 7.375% Senior Notes Due 2020 of Par Pharmaceutical Companies, Inc
08/14/13
EX-99.3
from S-4 3 pages Notice of Guaranteed Delivery
08/14/13
EX-99.4
from S-4 3 pages Offer to Exchange 7.375% Senior Notes Due 2020 for Any and All Outstanding 7.375% Senior Notes Due 2020 of Par Pharmaceutical Companies, Inc
08/14/13
Graphics & Data Files
GRAPHIC
from S-4 g556259exm_pg114.jpg
08/14/13
GRAPHIC
from S-4 g556259exm_pg115.jpg
08/14/13
GRAPHIC
from S-4 g556259exn_pg003a.jpg
08/14/13
GRAPHIC
from S-4 g556259exn_pg003b.jpg
08/14/13
GRAPHIC
from S-4 g556259exn_pg003c.jpg
08/14/13
GRAPHIC
from S-4 g556259exn_pg003d.jpg
08/14/13
GRAPHIC
from S-4 g556259exn_pg003e.jpg
08/14/13
GRAPHIC
from S-4 g556259exn_pg003f.jpg
08/14/13
GRAPHIC
from S-4 g556259exn_pg004.jpg
08/14/13
GRAPHIC
from S-4 g556259exo_pg025.jpg
08/14/13
GRAPHIC
from S-4 g556259exo_pg026.jpg
08/14/13
GRAPHIC
from S-4 g556259exp_pg199.jpg
08/14/13
GRAPHIC
from S-4 g556259exp_pg200.jpg
08/14/13
GRAPHIC
from S-4 g556259exp_pg201.jpg
08/14/13
GRAPHIC
from S-4 g556259exp_pg202.jpg
08/14/13
GRAPHIC
from S-4 g556259exp_pg203.jpg
08/14/13
GRAPHIC
from S-4 g556259exp_pg204.jpg
08/14/13
GRAPHIC
from S-4 g556259exp_pg205a.jpg
08/14/13
GRAPHIC
from S-4 g556259exp_pg205b.jpg
08/14/13
GRAPHIC
from S-4 g556259exp_pg206.jpg
08/14/13
GRAPHIC
from S-4 g556259exp_pg207.jpg
08/14/13
GRAPHIC
from S-4 g556259exp_pg208.jpg
08/14/13
GRAPHIC
from S-4 g556259exp_pg209.jpg
08/14/13
GRAPHIC
from S-4 g556259exp_pg210.jpg
08/14/13
GRAPHIC
from S-4 g556259exq_pg36.jpg
08/14/13
GRAPHIC
from S-4 g556259exq_pg37.jpg
08/14/13
GRAPHIC
from S-4 g556259exq_pg38.jpg
08/14/13
GRAPHIC
from S-4 g556259exq_pg39.jpg
08/14/13
GRAPHIC
from S-4 g556259exq_pg40a.jpg
08/14/13
GRAPHIC
from S-4 g556259exq_pg40b.jpg
08/14/13
GRAPHIC
from S-4 g556259exq_pg40c.jpg
08/14/13
GRAPHIC
from S-4 g556259exq_pg41.jpg
08/14/13
GRAPHIC
from S-4 g556259exr_pg013.jpg
08/14/13
GRAPHIC
from S-4 g556259exr_pg014a.jpg
08/14/13
GRAPHIC
from S-4 g556259exr_pg014b.jpg
08/14/13
GRAPHIC
from S-4 g556259exr_pg014c.jpg
08/14/13
GRAPHIC
from S-4 g556259exr_pg015.jpg
08/14/13
GRAPHIC
from S-4 g556259exs_pg005.jpg
08/14/13
GRAPHIC
from S-4 g556259exs_pg006.jpg
08/14/13
GRAPHIC
from S-4 g556259exs_pg007.jpg
08/14/13
GRAPHIC
from S-4 g556259exs_pg008a.jpg
08/14/13
GRAPHIC
from S-4 g556259exs_pg008b.jpg
08/14/13
GRAPHIC
from S-4 g556259exs_pg009.jpg
08/14/13
GRAPHIC
from S-4 g556259exs_pg010.jpg
08/14/13
GRAPHIC
from S-4 g556259exs_pg011.jpg
08/14/13
GRAPHIC
from S-4 g556259exs_pg012.jpg
08/14/13
GRAPHIC
from S-4 g556259exs_pg013.jpg
08/14/13
GRAPHIC
from S-4 g556259ext_pg006a.jpg
08/14/13
GRAPHIC
from S-4 g556259ext_pg006b.jpg
08/14/13
GRAPHIC
from S-4 g556259ext_pg006c.jpg
08/14/13
GRAPHIC
from S-4 g556259ext_pg006d.jpg
08/14/13
GRAPHIC
from S-4 g556259ext_pg007.jpg
08/14/13
GRAPHIC
from S-4 g556259ext_pg008.jpg
08/14/13
GRAPHIC
from S-4 g556259ext_pg009a.jpg
08/14/13
GRAPHIC
from S-4 g556259ext_pg009b.jpg
08/14/13
GRAPHIC
from S-4 g556259ext_pg010.jpg
08/14/13
GRAPHIC
from S-4 g556259ext_pg011.jpg
08/14/13
GRAPHIC
from S-4 g556259ext_pg012.jpg
08/14/13
GRAPHIC
from S-4 g556259ext_pg013.jpg
08/14/13
GRAPHIC
from S-4 g556259ext_pg014.jpg
08/14/13
GRAPHIC
from S-4 g556259g01d06.jpg
08/14/13
GRAPHIC
from S-4 g556259g11t28.jpg
08/14/13
GRAPHIC
from S-4 g556259g37v21.jpg
08/14/13
External Links